Pharma Partnership Growth Pangaea Data already collaborates with major pharma to enhance AI driven patient identification for trials and targeted therapies, signaling strong sales potential to other biopharma firms seeking scalable recruitment and real world data insights.

Clinical Care Gap The platform locates untreated and under treated patients in real world datasets and presents explainable insights for clinicians with minimal IT disruption, offering health systems a path to close care gaps, improve outcomes, and unlock new screening program revenue.

Regulatory Edge ISO compliance and medical grade processes position the product favorably for sale to regulated healthcare buyers and medical device manufacturers, reducing validation friction for enterprise deployments and CRO engagements.

AI Integration Strategic integrations with leading cloud providers and AI copilots create an attractive entry point for enterprises already using Microsoft and NVIDIA tech stacks, enabling smoother deployment and co selling opportunities.

Global Growth The company's cross-border footprint in key markets and substantial research funding signals scalable growth potential, with opportunities to partner across global health systems and EU-based pharma players.